Madison, WI, United States of America

David Itiro Kasahara

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sixth Streetlending Partners, as the Administrative Agent. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Itiro Kasahara: Innovator in RNAi Technology

Introduction

David Itiro Kasahara is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) agents. His work focuses on innovative solutions for inhibiting the expression of receptors associated with advanced glycation end-products.

Latest Patents

David holds a patent titled "RNAi Agents for Inhibiting Expression of Receptor for Advanced Glycation End-products, Compositions Thereof, and Methods of Use." This patent represents a crucial advancement in therapeutic strategies aimed at addressing various health conditions linked to these receptors. He has 1 patent to his name, showcasing his commitment to innovation in this specialized area.

Career Highlights

Currently, David serves as the Administrative Agent at Sixth Street Lending Partners. His role involves overseeing various administrative functions within the company, contributing to its operational efficiency. His expertise in biotechnology and patent development enhances the company's innovative capabilities.

Collaborations

David collaborates with talented professionals in his field, including Anthony Nicholas and Erik W. Bush. These partnerships foster a creative environment that encourages the exchange of ideas and advancements in their respective areas of expertise.

Conclusion

David Itiro Kasahara exemplifies the spirit of innovation in biotechnology through his patent work and professional contributions. His dedication to developing RNAi agents positions him as a key figure in advancing therapeutic solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…